If they don’t make comment on this finding formally, every...

First 11 Last

Share
Profile

Follow
pierre77

1,382 Posts.

54

05/02/19

19:33

Post #: 37340313
Share

Originally posted by pivalde: ↑

In my understanding Prana had given Bohlmann L et al group PBT2 to study it but Prana knew nothing about the results neither that their report was sent to a journal to be published. Thanks to HeadSet reading medical news bulletin and reporting these Prana news here on our board, I sent the abstract to Prana and they did not know anything of these results. But now they know ( Kempler and Stamler) , but even now no reaction. Yesterday Kempler was not in the office when I phoned to Prana and Stamler was most likely still sleeping in San Francisco. So it is not very quick to respond news.
Prana is a small company but a public company. They need to act very carefully and so it may take a bit time. Perhaps they need to talk first with the Bohlmann group, then to keep some kind of a meeting about what to do etc. This will change "the Sinclair deal", in fact this news can help Prana to get a lot of more money what is now planned with Sinclair.

This paper by Bahlmann et al is IMO a "Nobel prize" paper. Perhaps they did not want to have any Prana people as authors but they gave however credit to PBT2 as Prana's drug (????). Think what WHO Director-General told about present antibiotics, "On current trends, common diseases may become untreatable. Doctors facing patients will have to say, Sorry, there is nothing I can do for you." In any case this paper is very valuable to the authors, to Prana and in fighting severe infections.

Expand

If they don’t make comment on this finding formally, every shareholder should be hassling the board until they do.

PBT Price at posting: 3.9¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

CAF

IP anomaly thrills Cannidah with project extension hopes in QLD

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

ALY

Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

GRL

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

CMB

Asian Battery Metals uncover second massive sulphide discovery at Mongolia's Oval play

C1X

iTech inks deal with Chilean lithium giant to progress Reynolds Range

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ASX Market Open: Aussie market to leap on best 'Trump trade' bump since election day | November 22, 2024

PCL

HotCopper users react as Pancontinental Energy's trading halt lift reveals little

There are more pages in this discussion • 85 more messages in this thread...

First 11 Last

Add PBT (ASX) to my watchlist

If they don’t make comment on this finding formally, every...

Top Stories

IP anomaly thrills Cannidah with project extension hopes in QLD

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Asian Battery Metals uncover second massive sulphide discovery at Mongolia's Oval play

iTech inks deal with Chilean lithium giant to progress Reynolds Range

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ASX Market Open: Aussie market to leap on best 'Trump trade' bump since election day | November 22, 2024

HotCopper users react as Pancontinental Energy's trading halt lift reveals little

Featured News